Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
CC transcript
Inv. presentation
Quarterly results
Director departure
Emergent BioSolutions Inc. (EBS) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/02/2022 8-K/A Quarterly results
09/09/2021 8-K/A Quarterly results
04/30/2020 8-K/A Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "EMERGENT BIOSOLUTIONS REPORTS FINANCIAL RESULTS FOR FIRST QUARTER 2020",
"1Q20 Quarterly Supplement April 30, 2020 Safe Harbor Statement Safe Harbor Statement This"
12/12/2018 8-K/A Financial Statements and Exhibits
Docs: "Merger Agreement, among Emergent, PaxVax, Merger Sub and the PaxVax Shareholder Representative*, **†",
"Unaudited condensed consolidated financial statements of PaxVax Global, L.P. as of June 30, 2018 and for the six months ended June 30, 2018 and 2017 and accompanying notes thereto",
"Audited consolidated financial statements of PaxVax Global, L.P. as of and for the year ended December 31, 2017 and accompanying notes thereto",
"Unaudited pro forma condensed combined financial information of Emergent, PaxVax and Adapt as of June 30, 2018 and for the year ended December 31, 2017 and for the six months ended June 30, 2018 and accompanying notes thereto"
12/12/2018 8-K/A Financial Statements and Exhibits
Docs: "Share Purchase Agreement, between Emergent, the Adapt Sellers identified therein, Seamus Mulligan and Adapt Pharma Limited.*, **†",
"Unaudited condensed consolidated financial statements of Adapt as of June 30, 2018 and for the six months ended June 30, 2018 and 2017 and accompanying notes thereto",
"Audited consolidated financial statements of Adapt, as of December 31, 2017 and 2016, and for the years ended December 31, 2017, 2016 and 2015 and accompanying notes thereto",
"Unaudited pro forma condensed combined financial information of Emergent, PaxVax and Adapt as of June 30, 2018 and for the year ended December 31, 2017 and for the six months ended June 30, 2018 and accompanying notes thereto"
12/11/2013 8-K/A Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Presentation for investors"
01/13/2011 8-K/A Form 8-K/A - Current report [Amend]
08/13/2010 8-K/A Other Events
10/23/2007 8-K/A Form 8-K/A - Current report [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy